U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104916) titled 'Mindfulness-based Psilocybin Therapy for PTSD' on July 28.
Brief Summary: The goal of this study is to learn how psilocybin delivered with mindfulness-based therapy may help symptoms of posttraumatic stress disorder (PTSD). This is an assessor-blinded, randomized, controlled study in participants with PTSD. The study will investigate the changes in brain activity, connectivity, and microstructural neuroplasticity assessed using EEG/EMG and multimodal MRI measures after administration of one oral dose of psilocybin, accompanied either with standard "psychological support" only; or with standard support plus Mindfulness-based Cognitive...